Cancer Treatment Centers of America

We're available 24/7
(800) 615-3055

Chat online with us

Chat now

Other ways to contact us

Video
chat
(800) 615-3055

Have questions? Call (800) 615-3055 to speak to a cancer information specialist.
Or we can call you.

Tasigna®

Tasigna® is an oral chemotherapy drug used in the treatment of Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in some adult patients who have not responded well to other chemotherapy drugs (such as imatinib). Chronic myeloid leukemia (CML) accounts for about 15 percent of all cases of adult leukemia. The majority of CML cases have cells containing the abnormal Philadelphia chromosome. A tyrosine kinase inhibitor, Tasigna® works against cancerous cells by interfering with cell communication and growth.

Our results

our treatment results

View our patient survival rates, along with quality of life, patient loyalty and speed of care results.

See what CTCA is like

see what ctca is like

Learn about what to expect from your initial consultation through treatment at CTCA.

A team of cancer experts

an expert team just for you

At CTCA, you will be cared for by a team of experienced oncologists and other cancer experts.

Your browser (Internet Explorer 7) is out of date. Learn how to update your browser.